In order to provide equal access and equal opportunity to people with diverse abilities, this site has been designed with accessibility in mind. Click here to view

back to press releases

Senate Committee Approves Colorectal Cancer Bill

Senator Debbe Leftwich Senator Debbe Leftwich
Sen. Leftwich discusses cancer screening bill.

It is estimated that 1,880 Oklahomans will be diagnosed with colorectal cancer this year. Of those, 720 will die. That’s according to the American Cancer Society, which also reports that regular colorectal cancer screening could reduce deaths from that disease by as much as 80 percent. That’s why Sen. Debbe Leftwich has authored SB 14, which would require insurance companies to cover colorectal cancer screening. The bill was approved by the Senate Retirement and Insurance Committee on Thursday.

“Most people probably are not aware that colorectal cancer is the second leading cancer killer in the United States,” said Leftwich, D-Oklahoma City. “Unfortunately, less than half of all Americans 50 or older have been screened recently. Many times it is simply because they cannot afford it.”

Leftwich, who serves as Co-Chair of the Legislative Cancer Caucus, said that when colorectal cancer is diagnosed early, the five year survival rate is 90 percent. When it has spread to other organs, the five year
survival rate plummets to just 10 percent.

“Unfortunately, only 39 percent of colorectal cancers are diagnosed while in the early stages,” Leftwich said. “Twenty years ago we started working to increase access to breast cancer screening and we’ve seen better outcomes for women as a result. Now we need to do the same thing with colorectal cancer screening.”

Leftwich said some insurance companies do offer the screening, but others do not. She said it is actually more cost effective in the long run, for both the patient and the insurance companies, to cover screening that enables the disease to be detected in its early stages.

“The cost of adding coverage for screening would be about 55 cents per customer per month. If you compare that to the cost of treating colorectal cancer in later stages because of a lack of screening, the cost is about $8,000 per customer per month,” Leftwich said.

The measure now must be voted on by the full Senate.

Contact info
Senator Leftwich's Office - (405) 521-5557